🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
sEphB-HSA may prevent tumor cells from multiplying and blocks several compo...
Status
Unknown
Location
AIDS Healthcare Foundation
Start Date
2020-09-17
Trial ID
NCT03993106
Treatments Being Tested
The purpose of this phase II, single-arm, open-label, three center study is...
Status
Unknown
Location
USC / Norris Comprehensive Cancer Center
Start Date
2019-09-20
Trial ID
NCT04033432
Treatments Being Tested
sEphB-HSA may prevent tumor cells from multiplying and blocks several compo...
Status
Unknown
Location
Sarcoma Oncology Center
Start Date
2020-08-14
Trial ID
NCT04486781
Treatments Being Tested
This is a Phase I dose-escalation study of sEphB4-HSA in combination with c...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-01-06
Trial ID
NCT04091867
Treatments Being Tested
Patients with solid tumors that have high expression levels of EphrinB2 are...
Status
Recruiting
Location
Sarcoma Oncology Center
Start Date
2025-03-15
Trial ID
NCT06493552
Treatments Being Tested
This is a multi-cohort single arm phase II/screening trial of the combinati...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2016-11-21
Trial ID
NCT02717156
This trial studies the side effects of recombinant EphB4-HSA fusion protein...
Status
Terminated
Location
USC / Norris Comprehensive Cancer Center
Start Date
2017-04-20
Trial ID
NCT03146871
This phase I trial studies the side effects and best dose of recombinant Ep...
Status
Withdrawn
Location
USC / Norris Comprehensive Cancer Center
Start Date
2023-08-01
Trial ID
NCT03552796
Treatments Being Tested
This study is about an experimental drug called sEphB4-HSA (recombinant alb...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2012-09-06
Trial ID
NCT01642342
This phase II trial studies recombinant EphB4-HSA fusion protein (EphB4-HSA...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2018-02-13
Trial ID
NCT02799485